PARK7 and cancer: The deglycase-1 (DJ-1) protein is another promising target for cancer therapy owing to its roles in invasion, migration, and chemoresistance, and several reports have suggested that inhibition of Src phosphorylation by DADS could downregulate DJ-1 expression, thereby inhibiting leukemic cell migration and invasion [126].